Berberine — Stack & Timing
Educational timing and stacking information based on how Berberine has been studied. Not a prescription. Not medical advice.
This is educational information only. Consult a healthcare provider before starting any supplement.
Stack & Timing Guidance
Educational summary based on how Berberine has been studied and commonly used.
Commonly studied timing
Clinical trials consistently administered berberine with meals (typically 2–3 divided doses daily) to align with postprandial glucose and lipid spikes; taking it with food also helps reduce gastrointestinal side effects such as nausea and cramping.
Dose ranges used in studies
The most commonly studied regimen is 500 mg taken two to three times per day (totaling 1000–1500 mg/day); some trials have used phospholipid-bound formulations (e.g., berberine phospholipid) which may improve bioavailability at lower doses due to berberine's inherently poor oral absorption.
↑ These are ranges from research studies, not personal dosing recommendations. Discuss with a clinician.
Commonly paired with
Berberine significantly alters gut microbiota composition; co-administration with probiotics may help preserve beneficial bacterial populations and enhance metabolic outcomes in type 2 diabetes
Both compounds have complementary insulin-sensitizing and glucose-lowering mechanisms; combined use has been explored for additive glycemic benefit
Berberine meta-analyses indicate a beneficial effect on liver enzymes; co-stacking with hepatoprotective agents like milk thistle is common in clinical practice for patients with metabolic-associated fatty liver
Standard berberine has low bioavailability (~5%); phospholipid complexes are used to enhance absorption and improve insulin-sensitizing and hormonal effects, particularly studied in PCOS
Safety & interactions
Berberine is generally well tolerated at studied doses, but gastrointestinal effects (nausea, constipation, diarrhea, abdominal discomfort) are the most commonly reported adverse events; some experts, including Huberman, recommend cycling use (e.g., a few months on, time off) rather than continuous year-round supplementation, though long-term safety data from RCTs remain limited.
- •Metformin and other antidiabetic medications: additive blood glucose-lowering effects may increase risk of hypoglycemia
- •CYP3A4 and CYP2D6 substrates: berberine inhibits these enzymes and may increase plasma levels of drugs such as cyclosporine, certain statins, and some antiarrhythmics
- •Anticoagulants (e.g., warfarin): potential interaction via CYP enzyme inhibition altering drug metabolism
- •Cholesterol-lowering medications (statins, bile acid sequestrants): additive lipid-lowering effects possible, warranting monitoring
Berberine should be avoided during pregnancy and breastfeeding due to potential fetal toxicity (including neonatal jaundice risk). Individuals with hypotension, severe liver or kidney impairment, or those on narrow-therapeutic-index drugs (especially immunosuppressants or anticoagulants) should exercise caution and consult a clinician before use. Those already achieving target glycemic control on medications should be monitored closely to avoid hypoglycemia.